10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q3 2014

Filing Information

Form Type	10-Q
Accession Number	`0001104659-14-076822`
Period End Date	20140930
Filing Date	20141105
Fiscal Year	2014
Fiscal Period	Q3
XBRL Instance	cldx-20140930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 67 Cash Flow Statement 57

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.90M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.63M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$169.40M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$32.52M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$191.55M	USD	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$133.58M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$2.90M	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$489.00K	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.72M	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.84M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	89.25M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$229.82M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	89.44M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$305.19M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	89.44M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$9.97M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	89.25M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$10.72M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$22.06M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$22.82M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$148.00K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$99.00K	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Total Assets	`Assets`	$271.67M	USD	Point-in-time
Total Assets	`Assets`	$347.10M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.72M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$2.24M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$17.70M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$17.18M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$928.00K	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$2.19M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$20.35M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$21.61M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$6.95M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$10.68M	USD	Point-in-time
Total Liabilities	`Liabilities`	$32.29M	USD	Point-in-time
Total Liabilities	`Liabilities`	$27.30M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at September 30, 2014 and December 31, 2013	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at September 30, 2014 and December 31, 2013	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 89,436,933 and 89,246,832 Shares Issued and Outstanding at September 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$89.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 89,436,933 and 89,246,832 Shares Issued and Outstanding at September 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$89.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$662.72M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$668.60M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.62M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.67M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.75M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-345.68M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-431.94M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$319.80M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$239.37M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$271.67M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$347.10M	USD	Point-in-time

Income Statement 67 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$40.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$518.00K	USD	3 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$117.00K	USD	3 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$284.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$940.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$817.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$1.59M	USD	3 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$1.04M	USD	3 Qtrs
Product Royalties	`RoyaltyRevenue`	$2.33M	USD	3 Qtrs
Total Revenue	`Revenues`	$3.49M	USD	3 Qtrs
Total Revenue	`Revenues`	$2.11M	USD	3 Qtrs
Total Revenue	`Revenues`	$980.00K	USD	1 Quarter
Total Revenue	`Revenues`	$1.10M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$77.36M	USD	3 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$26.18M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$20.42M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$49.60M	USD	3 Qtrs
Royalty	`RoyaltyExpense`	$2.33M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$5.00M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$10.13M	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$3.58M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$14.37M	USD	3 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$760.00K	USD	3 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$760.00K	USD	3 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$24.25M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$92.49M	USD	3 Qtrs
Total Operating Expense	`CostsAndExpenses`	$31.44M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$62.82M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-23.27M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-59.33M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-90.38M	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-30.34M	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$4.12M	USD	3 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$682.00K	USD	3 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$2.26M	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$142.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$13.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$842.00K	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-59.49M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-86.26M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.14M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.08M	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.76	USD	3 Qtrs
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.29	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.97	USD	3 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	81.02M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	78.68M	shares	3 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.40M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.35M	shares	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-59.49M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-86.26M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.14M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.08M	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-4.00K	USD	3 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-3.00K	USD	3 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-3.00K	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-56.00K	USD	3 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-40.00K	USD	3 Qtrs
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-121.00K	USD	1 Quarter
Unrealized Gain (Loss) on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$138.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-86.30M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-59.55M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-23.00M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-28.21M	USD	1 Quarter

Cash Flow Statement 57 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-59.49M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-86.26M	USD	3 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-23.14M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.08M	USD	1 Quarter
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.76M	USD	3 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.42M	USD	3 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$760.00K	USD	3 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$760.00K	USD	3 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$754.00K	USD	3 Qtrs
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.23M	USD	3 Qtrs
Realized Gain on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$11.00K	USD	3 Qtrs
Gain (Loss) on Sales or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$21.00K	USD	3 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$4.72M	USD	3 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$3.40M	USD	3 Qtrs
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$97.00K	USD	3 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$2.42M	USD	3 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$846.00K	USD	3 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.43M	USD	3 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.46M	USD	3 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-267.00K	USD	3 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-49.00K	USD	3 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.95M	USD	3 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-740.00K	USD	3 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$4.99M	USD	3 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.43M	USD	3 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-79.32M	USD	3 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-52.71M	USD	3 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$30.68M	USD	3 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$89.22M	USD	3 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$92.40M	USD	3 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$146.16M	USD	3 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.90M	USD	3 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.77M	USD	3 Qtrs
Proceeds from Sales or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$21.00K	USD	3 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-63.60M	USD	3 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-58.71M	USD	3 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$114.19M	USD	3 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$1.16M	USD	3 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$2.93M	USD	3 Qtrs
Payments of Term Loan	`RepaymentsOfSecuredDebt`	$11.03M	USD	3 Qtrs
Payments of Other Liabilities	`RepaymentsOfOtherLongTermDebt`	$44.00K	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.16M	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$106.05M	USD	3 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-4.00K	USD	3 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-3.00K	USD	3 Qtrs
Net Decrease in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-10.27M	USD	3 Qtrs
Net Decrease in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-136.88M	USD	3 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.90M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$14.63M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$169.40M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$32.52M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.90M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$14.63M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$169.40M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$32.52M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.